(Adnkronos) - “E’ chiaro che bisogna fare un lavoro sostenibile in tutte le regioni perché altrimenti si creano disparità di popolazione. Quello della tecnologia mRna è un tema che va considerato su larga scala nell'ambito di tutto il calendario vaccinale affinché possa essere garantito a tutta la popolazione target che potrebbe esserne avvantaggiata nei confronti delle malattie verso cui i vaccini lavorano”. Così, Francesca Russo, direttore della direzione Prevenzione, sicurezza alimentare, veterinaria Regione Veneto, nel contesto dell’expert advisory panel sulla promozione dell'innovazione della tecnologia mRna.
Category
🗞
NewsTranscript
00:00I believe that the production of vaccines, the new technologies are always to be taken into consideration.
00:14So, if this RNA technology can lead us to vaccines that have a faster availability,
00:25to a greater effectiveness also for an effect of amplification that they produce at the immune level,
00:34certainly I believe that it will be necessary to review also those that can be the new availability of vaccines,
00:43because they are more effective, but also because they are aimed at new viral diseases.
00:49So, I believe that it is absolutely necessary to consider the expansion of the vaccine calendar.
00:56It is clear that it is also necessary to do a job that is sustainable in all regions,
01:04because otherwise population disparities are created.
01:08So, availability must also be considered, and this is a topic that must be considered on a large scale,
01:15precisely in the context of the entire vaccine calendar.
01:18It is important that it is included in the vaccine calendar,
01:21precisely because it can be guaranteed to the entire target population,
01:24which could benefit from it compared to the diseases towards which vaccines work,
01:33to prevent them from manifesting.